David R. McCready

15.5k citations

215 papers · 9.7k indexed · 4 hit papers · h-index 49

Impact in

Cancer Research top 0.1%
- Breast Cancer Treatment Studies
Pathology and Forensic Medicine top 0.2%
- Breast Lesions and Carcinomas

Papers in

Cancer Research 117
- Breast Cancer Treatment Studies 103
Pathology and Forensic Medicine 69
- Breast Lesions and Carcinomas 61

Co-authors: Maureen Trudeau Michael Reedijk Naomi Miller Wey L. Leong Anthony Fyles Melania Pintilie Claire Holloway Wedad Hanna
Journals: Annals of Surgical Oncology (33 papers)Journal of Clinical Oncology (18 papers)Breast Cancer Research and Treatment (17 papers)The Breast Journal (8 papers)Journal of Surgical Oncology (8 papers)
Partner nations: Canada United States New Zealand

In The Last Decade

David R. McCready

210 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study 2014 · 555 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Journal of Clinical Oncology
2007 The Lancet Oncology
2005 Cancer Research
2000 Metabolism

Peers

Countries citing papers authored by David R. McCready

Since Specialization

Citations

This map shows the geographic impact of David R. McCready's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. McCready with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. McCready more than expected).

Fields of papers citing papers by David R. McCready

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. McCready. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. McCready. The network helps show where David R. McCready may publish in the future.

Co-authors

The 25 scholars most cited alongside David R. McCready, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David R. McCready Line = papers co-authored together David R. McCready links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pain Self-Management Behaviors in Breast Cancer Survivors Six Months Post-Primary Treatment: A Mixed-Methods, Descriptive Study Cancers ·Kaitlin McGarragle, S. Lilly Zheng, Lucia Gagliese, Doris Howell, Elizabeth Edwards, Cheryl Pritlove, David R. McCready, Christine Elser, Jennifer M. Jones, Lynn R. Gauthier	2025	0
2	Primary MALT lymphoma of the breast: pathological and radiological characteristics Breast Cancer Research and Treatment ·Yukiko Shibahara, Jan Delabie, Supriya Kulkarni, Allison Grant, Anca Prica, David R. McCready, Susan J. Done	2024	1
3	Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer Journal of Clinical Oncology ·Martin Sjöström, Anthony Fyles, Fei‐Fei Liu, David R. McCready, Wei Shi, Katrina Rey‐McIntyre, S. Laura Chang, Felix Y. Feng, Corey Speers, Lori J. Pierce, Erik Holmberg, Mårten Fernö, Per Malmström, Per Karlsson	2023	21
4	Utilization of a rapid diagnostic centre during the COVID-19 pandemic reduced diagnostic delays in breast cancer The American Journal of Surgery ·Gary T.C. Ko, Sangita Sequeira, David R. McCready, Sharmy Sarvanantham, Nancy Li, Shelley Westergard, Vrutika Prajapati, Vivianne Freitas, Tulin Cil	2022	1
5	Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical‐sonography features helping to differentiate fibroadenomas and phyllodes tumor? Journal of Surgical Oncology ·Basma Al‐Arnawoot, Anabel M. Scaranelo, Rachel Fleming, Supriya Kulkarni, Ravi Menezes, David R. McCready, Susan J. Done, Vivianne Freitas	2020	7
6	Screening women at high risk for breast cancer: one program fits all? Breast Cancer Research and Treatment ·Naama Hermann, Adi J. Klil‐Drori, Fernando A. Angarita, Shelley Westergard, Vivianne Freitas, Anabel M. Scaranelo, David R. McCready, Tulin Cil	2020	4
7	Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care Canadian Journal of Public Health ·Kristina M. Blackmore, Ashini Weerasinghe, Claire Holloway, Vicky Majpruz, Lucia Mirea, Frances P. O’Malley, Cathy Paroschy Harris, Ashley Hendry, Amanda Hey, Anat Kornecki, G. W. Lougheed, Barbara-Anne Maier, Patricia Marchand, David R. McCready, Carol Rand, Simon Raphael, Roanne Segal-Nadler, Neelu Sehgal, Derek Muradali, Anna M. Chiarelli	2019	7
8	Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma Clinical Cancer Research ·Aras Toker, Linh T. Nguyen, Simone C. Stone, S.Y. Cindy Yang, Sarah Rachel Katz, Patricia A. Shaw, Blaise Clarke, Danny Ghazarian, Ayman Al‐Habeeb, Alexandra Easson, Wey L. Leong, David R. McCready, Michael Reedijk, Cynthia J. Guidos, Trevor J. Pugh, Marcus Q. Bernardini, Pamela S. Ohashi	2018	85
9	Validity of Administrative Databases in Comparison to Medical Charts for Breast Cancer Treatment Data SHILAP Revista de lepidopterología ·Ashini Weerasinghe, Courtney R. Smith, Vicky Majpruz, Anjali Pandya, Kristina M. Blackmore, Claire Holloway, Roanne Segal-Nadlere, Cathy Paroschy Harris, Ashley Hendry, Amanda Hey, Anat Kornecki, G. W. Lougheed, Barbara-Anne Maier, Patricia Marchand, David R. McCready, Carol Rand, Simon Raphael, Neelu Sehgal, Anna M. Chiarelli	2018	4
10	Smartphone-Enabled Health Coaching Intervention (iMOVE) to Promote Long-Term Maintenance of Physical Activity in Breast Cancer Survivors: Protocol for a Feasibility Pilot Randomized Controlled Trial JMIR Research Protocols ·Paul Ritvo, Maya Obadia, Daniel Santa Mina, Shabbir M.H. Alibhai, Catherine M. Sabiston, Paul Oh, Kristin L. Campbell, David R. McCready, Leslie E. Auger, Jennifer M. Jones	2017	28
11	Preoperative MRI of the breast and ipsilateral breast tumor recurrence: Long‐term follow up Journal of Surgical Oncology ·Mai‐Kim Gervais, Ellen Maki, Dan Schiller, Pavel Crystal, David R. McCready	2017	20
12	How do the characteristics of breast cancer diagnostic assessment programmes influence service delivery: A mixed methods study European Journal of Cancer Care ·Anna R. Gagliardi, Gladys Honein‐AbouHaidar, Terri Stuart-McEwan, Jennifer Smylie, Angel Arnaout, Jean M. Seely, Frances C. Wright, Mark Dobrow, Melissa Brouwers, Karina Bukhanov, David R. McCready	2017	5
13	B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity Cancer Immunology Research ·Ramtin Rahbar, Albert Lin, Magar Ghazarian, Helen Loo Yau, Sangeetha Paramathas, Philipp A. Lang, Anita Schildknecht, Alisha R. Elford, Carlos R. Garcia-Batres, Bernard Martin, Hal K. Berman, Wey L. Leong, David R. McCready, Michael Reedijk, Susan J. Done, Naomi Miller, Bruce Youngson, Woong‐Kyung Suh, Tak W. Mak, Pamela S. Ohashi	2014	38
14	Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival PLoS ONE ·Thomas R. Cawthorn, Juan Carlos Alvarez Moreno, Moyez Dharsee, Danh Tran‐Thanh, Suzanne Ackloo, Pei Zhu, Girish Sardana, Jian Chen, Peter Kupchak, Lindsay M. Jacks, Naomi Miller, Bruce Youngson, Vladimir V. Iakovlev, Cynthia J. Guidos, Katherine A. Vallis, Kenneth Evans, David R. McCready, Wey L. Leong, Susan J. Done	2012	70
15	MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer Cancer Research ·Wei Shi, Kate Gerster, Nehad M. Alajez, Jasmine Tsang, Levi Waldron, Melania Pintilie, Angela Bik‐Yu Hui, Jenna Sykes, Christine P’ng, Naomi Miller, David R. McCready, Anthony Fyles, Fei‐Fei Liu	2011	227
16	Risk Assessment and Class-Based Evaluation of Three Phosphate Esters Human and Ecological Risk Assessment An International Journal ·Nancy Anne M. Berdasco, David R. McCready	2011	8
17	Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use Carcinogenesis ·William Chu, Anthony Fyles, Edward M. Sellers, David R. McCready, Joan Murphy, Tuya Pal, Steven A. Narod	2007	29
18	High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival Cancer Research ·Michael Reedijk, Silvia Odorcic, Lynn Chang, Hui Zhang, Naomi Miller, David R. McCready, Gina Lockwood, Sean E. Egan Hit paper breakdown →	2005	615
19	Sentinel lymph-node biopsy in breast cancer. Europe PMC (PubMed Central) ·David R. McCready, A. Bodurtha, Noelle Davis, Sarkis Meterissian, J Robert, Walley Temple	1999	9
20	Lack of Comparability Between Binding of Monoclonal Antibodies to Melanoma Cells In Vitro and Localization In Vivo JNCI Journal of the National Cancer Institute ·David R. McCready, Charles M. Balch, Isaiah J. Fidler, James L. Murray	1989	13

About David R. McCready

David R. McCready is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Dermatology and Genetics, having authored 215 papers that have together received 9.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (103 papers), Breast Lesions and Carcinomas (61 papers), Breast Implant and Reconstruction (40 papers), Global Cancer Incidence and Screening (25 papers), BRCA gene mutations in cancer (21 papers), Cancer survivorship and care (17 papers), Cutaneous Melanoma Detection and Management (15 papers) and Cancer Risks and Factors (11 papers). The work is most often cited by research in Cancer Research (5.0k citations), Pathology and Forensic Medicine (2.7k citations), Oncology (4.1k citations), Surgery (2.3k citations) and Dermatology (303 citations). David R. McCready has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Maureen Trudeau, Michael Reedijk, Naomi Miller, Wey L. Leong, Anthony Fyles, Melania Pintilie, Claire Holloway, Wedad Hanna, L. Manchul and Ivo A. Olivotto. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment, The Breast Journal and Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact